The barriers to patient-driven treatment in mental health: why patients may choose to follow their own path.
OBJECTIVE
The paper aims to explore the barriers that currently exist to patient-driven treatment within the field of mental health care and reform.


METHODS
This study represents action learning research using grounded theory to explore a possible causal basis for recidivism related to non-compliance with medication. Interviews addressed concerns from the literature around perceived barriers to patient-driven treatment evidenced by non-compliance with medically recommended pharmaceutical treatment. Results were correlated to look for emergent themes that were used to form the basis for subsequent interview questions.


RESULTS
An analysis of the resulting emergent themes illustrated the importance of participatory treatment and coaching rather than medically applied paternalistic care, which is seen as encouraging learned helplessness on the part of patients. Similar helplessness was also revealed in clinicians themselves. Patients' awareness of their own needs and demands for more services place clients and the caregivers at odds over appropriate care in an environment of limited resources.


CONCLUSIONS
The research was limited to only a small number of interviewees in one institution, all of whom were closely associated with mental illness in various capacities. The grounded theory nature of the research does, however, provide a framework for more research in other institutions to test and further explore some of the findings.


CONCLUSIONS
The study demonstrated a reinforcement of Maslow's theory of needs hierarchy. The study illustrated a step-wise approach to treatment to decrease the rate of failure and recidivism in mental health care. The provision of a stable living environment was viewed as instrumental in improving patients' compliance with pharmaceutical treatment. An action plan was therefore created to initiate the support of a transitional/emergency house by various community groups in partnership with pharmaceutical manufacturing companies.


CONCLUSIONS
Recidivism in mental health-created by non-compliance in pharmaceutical treatment, is a major issue in Canada's health care system. This study brings to the forefront issues from a number of perspectives in order to form a course of action in response to its findings.
Greenall
Paul
P
Ministry of Health and Long Time Care, Penetanguishene, Canada.
D035841:Behavioral Research; D017281:Cost of Illness; D006208:Halfway Houses; D006302:Health Services Research; D006380:Helplessness, Learned; D006778:Hospitals, Psychiatric / Q000191:economics / Q000458:organization & administration / Q000706:statistics & numerical data; D006801:Humans; D007258:Informed Consent; D007407:Interviews as Topic; D001523:Mental Disorders / Q000188:drug therapy* / Q000191:economics; D008605:Mental Health Services / Q000191:economics / Q000458:organization & administration* / Q000706:statistics & numerical data; D009864:Ontario; D026706:Paternalism; D010349:Patient Compliance / Q000523:psychology*; D010358:Patient Participation; D010359:Patient Readmission; D018802:Patient-Centered Care; D010817:Physician-Patient Relations; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000627:therapeutic use*
D011619:Psychotropic Drugs